Profilo
Gary M.
Noonan held several director positions in pharmaceutical companies such as Aarden Pharmaceuticals, Eli Lilly & Co., CoLucid Pharmaceuticals, and Muroplex Therapeutics.
He obtained an undergraduate degree in 1975 and an MBA in 1978, both from Indiana University.
Precedenti posizioni note di Gary M. Noonan
| Società | Posizione | Fine |
|---|---|---|
Aarden Pharmaceuticals, Inc.
 Aarden Pharmaceuticals, Inc. BiotechnologyHealth Technology Aarden Pharmaceuticals, Inc. operated as a drug discovery and biotechnology company. The company was founded by Thomas M. Estok, Christopher C. LeMasters, Francis Burrows and Zhong-Yin Zhang in 2008 and was headquartered in Indianapolis, GA. | Amministratore Delegato | - |
| COLUCID PHARMACEUTICALS INC | Direttore/Membro del Consiglio | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Muroplex Therapeutics, Inc.
 Muroplex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Muroplex Therapeutics, Inc. engages in the manufacture of pharmaceutical preparations. It focuses on directing immunity in humans and animals by rational manipulation of natural molecular signals that drive immune response. The company was founded by Larry C. Blaszczak and David E. Seitz on September 27, 2005 and is headquartered in Indianapolis, IN. | Direttore/Membro del Consiglio | - |
Formazione di Gary M. Noonan
| Indiana University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 3 |
|---|---|
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. BiotechnologyHealth Technology CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA. | Health Technology |
Muroplex Therapeutics, Inc.
Muroplex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Muroplex Therapeutics, Inc. engages in the manufacture of pharmaceutical preparations. It focuses on directing immunity in humans and animals by rational manipulation of natural molecular signals that drive immune response. The company was founded by Larry C. Blaszczak and David E. Seitz on September 27, 2005 and is headquartered in Indianapolis, IN. | Health Technology |
Aarden Pharmaceuticals, Inc.
Aarden Pharmaceuticals, Inc. BiotechnologyHealth Technology Aarden Pharmaceuticals, Inc. operated as a drug discovery and biotechnology company. The company was founded by Thomas M. Estok, Christopher C. LeMasters, Francis Burrows and Zhong-Yin Zhang in 2008 and was headquartered in Indianapolis, GA. | Health Technology |
- Borsa valori
- Insiders
- Gary M. Noonan